株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

米国の心調律管理、電気生理学、心臓アブレーション市場 (2019~2025年)

Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market | US | 2019-2025 | MedSuite

発行 iData Research Inc. 商品コード 915024
出版日 ページ情報 英文 518 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.53円で換算しております。

※ Single Userライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。
認証されたPC上のみでの閲覧となっております。

Back to Top
米国の心調律管理、電気生理学、心臓アブレーション市場 (2019~2025年) Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market | US | 2019-2025 | MedSuite
出版日: 2019年08月02日 ページ情報: 英文 518 Pages
概要

2018年、米国の心調律管理、電気生理学、心臓アブレーション市場は大きく拡大しました。これらは救命器具であり、米国の高齢化もあいまって、同市場のすべてのセグメントで拡大を続けています。

当レポートでは、米国の心調律管理、電気生理学、心臓アブレーション市場について調査し、市場の動向とセグメント別動向、国別予測、製品ポートフォリオについてまとめています。

第1章 調査方法

第2章 疾患概要

  • 疾患の治療と診断
  • 不整脈のタイプ
  • 心不全
  • 心臓発作
  • 患者人口統計

第3章 製品評価

  • イントロダクション
  • 製品ポートフォリオ
    • ペースメーカー
    • ICD
    • CRT機器
    • 心臓リード
    • 体外除細動器
    • ラボシステム
    • 診断用EPカテーテル
    • 心臓アブレーションカテーテル
  • FDAリコール
  • 治験

第4章 米国の心調律管理、電気生理学、心臓アブレーション市場概要

  • イントロダクション
  • 市場概要
  • セグメント別動向分析
  • 促進因子と制限因子
  • 競合市場シェア分析
  • 合併・買収
  • 企業プロファイル
  • SWOT分析

第5章 手技件数

第6章 ペースメーカー市場

第7章 ICD市場

第8章 CRT機器市場

第9章 心臓リード市場

第10章 心電計モニタリング市場

第11章 ラボシステム市場

第12章 診断用電気生理学カテーテル市場

第13章 心臓アブレーションカテーテル市場

図表

LIST OF CHARTS

LIST OF CHARTS

  • Chart 1 1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, U.S., 2015 - 2025
  • Chart 1 2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Overview, U.S., 2018 & 2025
  • Chart 4 1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, U.S., 2015 - 2025
  • Chart 4 2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Breakdown, U.S., 2018
  • Chart 4 3: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Breakdown, U.S., 2025
  • Chart 4 4: Growth Rates by Segment, Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, U.S., 2016 - 2025
  • Chart 4 5: Leading Competitors, Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, U.S., 2018
  • Chart 5 1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Procedures by Type, U.S., 2015 - 2025
  • Chart 6 1: Pacemaker Market by Segment, U.S., 2015 - 2025
  • Chart 6 2: Pacemaker Market Breakdown, U.S., 2018
  • Chart 6 3: Pacemaker Market Breakdown, U.S., 2025
  • Chart 6 4: Total Pacemaker Market, U.S., 2015 - 2025
  • Chart 6 5: Single-Chamber Pacemaker Market by Segment, U.S., 2015 - 2025
  • Chart 6 6: Total Single-Chamber Pacemaker Market, U.S., 2015 - 2025
  • Chart 6 7: Initial Placement Single-Chamber Pacemaker Market, U.S., 2015 - 2025
  • Chart 6 8: Replacement Single-Chamber Pacemaker Market, U.S., 2015 - 2025
  • Chart 6 9: Dual-Chamber Pacemaker Market by Segment, U.S., 2015 - 2025
  • Chart 6 10: Total Dual-Chamber Pacemaker Market, U.S., 2015 - 2025
  • Chart 6 11: Initial Placement Dual-Chamber Pacemaker Market, U.S., 2015 - 2025
  • Chart 6 12: Replacement Dual-Chamber Pacemaker Market, U.S., 2015 - 2025
  • Chart 6 13: Leadless Pacemaker Market, U.S., 2015 - 2025
  • Chart 6 14: Leading Competitors, Pacemaker Market, U.S., 2018
  • Chart 7 1: ICD Market by Segment, U.S., 2015 - 2025
  • Chart 7 2: ICD Market Breakdown, U.S., 2018
  • Chart 7 3: ICD Market Breakdown, U.S., 2025
  • Chart 7 4: Total ICD Market, U.S., 2015 - 2025
  • Chart 7 5: Single-Chamber ICD Market by Segment, U.S., 2015 - 2025
  • Chart 7 6: Total Single-Chamber ICD Market, U.S., 2015 - 2025
  • Chart 7 7: Initial Placement Single-Chamber ICD Market, U.S., 2015 - 2025
  • Chart 7 8: Replacement Single-Chamber ICD Market, U.S., 2015 - 2025
  • Chart 7 9: Dual-Chamber ICD Market by Segment, U.S., 2015 - 2025
  • Chart 7 10: Total Dual-Chamber ICD Market, U.S., 2015 - 2025
  • Chart 7 11: Initial Placement Dual-Chamber ICD Market, U.S., 2015 - 2025
  • Chart 7 12: Replacement Dual-Chamber ICD Market, U.S., 2015 - 2025
  • Chart 7 13: S-ICD Market, U.S., 2015 - 2025
  • Chart 7 14: Leading Competitors, ICD Market, U.S., 2018
  • Chart 8 1: Cardiac Resynchronization Therapy Device Market by Segment, U.S., 2015 - 2025
  • Chart 8 2: Cardiac Resynchronization Therapy Device Market Breakdown, U.S., 2018
  • Chart 8 3: Cardiac Resynchronization Therapy Device Market Breakdown, U.S., 2025
  • Chart 8 4: Total CRT Market, U.S., 2015 - 2025
  • Chart 8 5: CRT-P Market by Segment, U.S., 2015 - 2025
  • Chart 8 6: Total CRT-P Market, U.S., 2015 - 2025
  • Chart 8 7: Initial Placement CRT-P Market, U.S., 2015 - 2025
  • Chart 8 8: Replacement CRT-P Market, U.S., 2015 - 2025
  • Chart 8 9: CRT-D Market by Segment, U.S., 2015 - 2025
  • Chart 8 10: Total CRT-D Market, U.S., 2015 - 2025
  • Chart 8 11: Initial Placement CRT-D Market, U.S., 2015 - 2025
  • Chart 8 12: Replacement CRT-D Market, U.S., 2015 - 2025
  • Chart 8 13: Leading Competitors, CRT Market, U.S., 2018
  • Chart 9 1: Cardiac Lead Market by Segment, U.S., 2015 - 2025
  • Chart 9 2: Cardiac Lead Market Breakdown, U.S., 2018
  • Chart 9 3: Cardiac Lead Market Breakdown, U.S., 2025
  • Chart 9 4: Total Cardiac Lead Market, U.S., 2015 - 2025
  • Chart 9 5: Pacing Lead Market, U.S., 2015 - 2025
  • Chart 9 6: Defibrillation Lead Market, U.S., 2015 - 2025
  • Chart 9 7: LV Lead Market, U.S., 2015 - 2025
  • Chart 9 8: Leading Competitors, Cardiac Lead Market, U.S., 2018
  • Chart 10 1: Electrocardiography Monitoring Market by Segment, U.S., 2015 - 2025
  • Chart 10 2: Electrocardiography Monitoring Market Breakdown, U.S., 2018
  • Chart 10 3: Electrocardiography Monitoring Market Breakdown, U.S., 2025
  • Chart 10 4: Resting ECG Device Market by Segment, U.S., 2015 - 2025
  • Chart 10 5: Total Resting ECG Device Market, U.S., 2015 - 2025
  • Chart 10 6: Hospital-Based Resting ECG Device Market, U.S., 2015 - 2025
  • Chart 10 7: Office-Based Resting ECG Device Market by Segment, U.S., 2015 - 2025
  • Chart 10 8: Total Office-Based Resting ECG Device Market, U.S., 2015 - 2025
  • Chart 10 9: Purpose-Built Office-Based Resting ECG Device Market, U.S., 2015 - 2025
  • Chart 10 10: PC-Based Office-Based Resting ECG Device Market, U.S., 2015 - 2025
  • Chart 10 11: Stress Testing Device Market by Segment, U.S., 2015 - 2025
  • Chart 10 12: Total Stress Testing Device Market, U.S., 2015 - 2025
  • Chart 10 13: Hospital-Based Stress Testing Device Market, U.S., 2015 - 2025
  • Chart 10 14: Office-Based Stress Testing Device Market, U.S., 2015 - 2025
  • Chart 10 15: Holter Monitoring Recorder Market by Segment, U.S., 2015 - 2025
  • Chart 10 16: Total Holter Monitoring Recorder Market, U.S., 2015 - 2025
  • Chart 10 17: Hospital-Based Holter Monitoring Recorder Market, U.S., 2015 - 2025
  • Chart 10 18: Office-Based Holter Monitoring Recorder Market, U.S., 2015 - 2025
  • Chart 10 19: IDTF Holter Monitoring Recorder Market, U.S., 2015 - 2025
  • Chart 10 20: Leading Competitors, Electrocardiography Monitoring Market, U.S., 2018
  • Chart 11 1: Lab Systems Market by Segment, U.S., 2015 - 2025
  • Chart 11 2: Lab Systems Market Breakdown, U.S., 2018
  • Chart 11 3: Lab Systems Market Breakdown, U.S., 2025
  • Chart 11 4: 3D Mapping Market, U.S., 2015 - 2025
  • Chart 11 5: EP Recording Market, U.S., 2015 - 2025
  • Chart 11 6: RF Ablation Generator Market, U.S., 2015 - 2025
  • Chart 11 7: Remote Steering System Market, U.S., 2015 - 2025
  • Chart 11 8: Leading Competitors, Lab Systems Market, U.S., 2018
  • Chart 12 1: Diagnostic Electrophysiology Catheters Market by Segment, U.S., 2015 - 2025
  • Chart 12 2: Diagnostic Electrophysiology Catheters Market Breakdown, U.S., 2018
  • Chart 12 3: Diagnostic Electrophysiology Catheters Market Breakdown, U.S., 2025
  • Chart 12 4: Total Diagnostic Electrophysiology Catheters Market, U.S., 2015 - 2025
  • Chart 12 5: EP Conventional Catheter Market by Segment, U.S., 2015 - 2025
  • Chart 12 6: Total EP Conventional Catheter Market, U.S., 2015 - 2025
  • Chart 12 7: Fixed EP Catheter Market, U.S., 2015 - 2025
  • Chart 12 8: Steerable EP Catheter Market, U.S., 2015 - 2025
  • Chart 12 9: EP Advanced Catheter Market, U.S., 2015 - 2025
  • Chart 12 10: ICE Diagnostic Catheter Market, U.S., 2015 - 2025
  • Chart 12 11: Leading Competitors, Diagnostic Electrophysiology Catheters Market, U.S., 2018
  • Chart 13 1: Cardiac Ablation Catheter Market by Segment, U.S., 2015 - 2025
  • Chart 13 2: Cardiac Ablation Catheter Market Breakdown, U.S., 2018
  • Chart 13 3: Cardiac Ablation Catheter Market Breakdown, U.S., 2025
  • Chart 13 4: Cardiac Ablation Catheter Market, U.S., 2015 - 2025
  • Chart 13 5: RF Ablation Market by Segment, U.S., 2015 - 2025
  • Chart 13 6: Total RF Ablation Catheter Market, U.S., 2015 - 2025
  • Chart 13 7: Irrigated RF Ablation Catheter Market, U.S., 2015 - 2025
  • Chart 13 8: Non-Irrigated RF Ablation Catheter Market, U.S., 2015 - 2025
  • Chart 13 9: Cryoablation Catheter Market, U.S., 2015 - 2025
  • Chart 13 10: Leading Competitors, Cardiac Ablation Catheter Market, U.S., 2018
  • Chart 14 1: ICE Generator Market, U.S., 2015 - 2025
  • Chart 14 2: Leading Competitors, ICE Generator Market, Europe, 2018
  • Chart 15 1: Cryoablation Generator Market, U.S., 2015 - 2025
  • Chart 16 1: External Defibrillator Market by Segment, U.S., 2015 - 2025
  • Chart 16 2: External Defibrillator Market Breakdown, U.S., 2018
  • Chart 16 3: External Defibrillator Market Breakdown, U.S., 2025
  • Chart 16 4: Total External Defibrillator Market, U.S., 2015 - 2025
  • Chart 16 5: Automated External Defibrillator Market, U.S., 2015 - 2025
  • Chart 16 6: Wearable Cardioverter Defibrillator Market, U.S., 2015 - 2025
  • Chart 16 7: Leading Competitors, External Defibrillator Market, U.S., 2018

LIST OF FIGURES

LIST OF FIGURES

  • Figure 1 1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Share Ranking by Segment, U.S., 2018 (1 of 2)
  • Figure 1 2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Share Ranking by Segment, U.S., 2018 (2 of 2)
  • Figure 1 3: Companies Researched in this Report
  • Figure 1 4: Factors Impacting the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, U.S. (1 of 2)
  • Figure 1 5: Factors Impacting the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, U.S. (2 of 2)
  • Figure 1 6: Recent Events in the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, 2015 - 2018 (1 of 3)
  • Figure 1 7: Recent Events in the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, 2015 - 2018 (2 of 3)
  • Figure 1 8: Recent Events in the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, 2015 - 2018 (3 of 3)
  • Figure 1 9: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Procedures Covered
  • Figure 1 10: Procedure Codes Investigated
  • Figure 1 11: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Markets Covered, (1 of 2)
  • Figure 1 12: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Markets Covered, (2 of 2)
  • Figure 1 13: Key Report Updates
  • Figure 1 14: Version History
  • Figure 3 1: Pacemaker Market Products by Company
  • Figure 3 2: ICD Market Products by Company
  • Figure 3 3: CRT Device Market Products by Company
  • Figure 3 4: Cardiac Leads Market Products by Company
  • Figure 3 5: External Defibrillator Market Products by Company
  • Figure 3 6: Lab Systems Market Products by Company
  • Figure 3 7: Diagnostic EP Catheter Market Products by Company
  • Figure 3 8: Cardiac Ablation Catheter Products by Company (1 of 2)
  • Figure 3 9: Cardiac Ablation Catheter Products by Company (2 of 2)
  • Figure 3 10: Class 2 Device Recall Assurity
  • Figure 3 11: Class 2 Device Recall Zenex
  • Figure 3 12: Class 2 Device Recall Accent family of pacemakers
  • Figure 3 13: Class 1 Device Recall Fortify, Fortify Assura
  • Figure 3 14: Class 1 Device Recall Fortify, Unify, Assura, including Quadra
  • Figure 3 15: Class 2 Device Recall Ellipse
  • Figure 3 16: Class 2 Device Recall Allure Quadra
  • Figure 3 17: Class 2 Device Recall Anthem, Allure
  • Figure 3 18: Class 2 Device Recall Nuance
  • Figure 3 19: Class 1 Device Recall Optisure HV lead
  • Figure 3 20: Class 3 Device Recall FIRMap 60mm Catheter
  • Figure 3 21: Class 2 Device Recall TactiSys Quartz Pack, PN004 400
  • Figure 3 22: Class 2 Device Recall SMARTABLATE RF Generator System
  • Figure 3 23: Class 2 Device Recall ESSENTIO Pacemaker
  • Figure 3 24: Class 2 Device Recall PROPONENT Pacemaker
  • Figure 3 25: Class 2 Device Recall ACCOLADE Pacemaker
  • Figure 3 26: Class 2 Device Recall PROPONENT SR Pacemaker
  • Figure 3 27: Class 2 Device Recall PROPONENT DR Pacemaker
  • Figure 3 28: Class 2 Device Recall PROPONENT EL DR Pacemaker
  • Figure 3 29: Class 2 Device Recall PROPONENT VDD SL Pacemaker
  • Figure 3 30: Class 2 Device Recall PROPONENT VDD SL Pacemaker
  • Figure 3 31: Class 2 Device Recall ACCOLADE MRI EL DR Pacemaker
  • Figure 3 32: Class 2 Device Recall ACCOLADE MRI DR Pacemaker
  • Figure 3 33: Class 2 Device Recall ACCOLADE MRI SR Pacemaker
  • Figure 3 34: Class 2 Device Recall ACCOLADE EL DR Pacemaker
  • Figure 3 35: Class 2 Device Recall ACCOLADE DR Pacemaker
  • Figure 3 36: Class 2 Device Recall ACCOLADE SR Pacemaker
  • Figure 3 37: Class 2 Device Recall ESSENTIO MRI EL DR Pacemaker
  • Figure 3 38: Class 2 Device Recall ESSENTIO MRI DR Pacemaker
  • Figure 3 39: Class 2 Device Recall ESSENTIO MRI SR Pacemaker
  • Figure 3 40: Class 2 Device Recall ESSENTIO DR Pacemaker
  • Figure 3 41: Class 2 Device Recall ESSENTIO SR Pacemaker
  • Figure 3 42: Class 2 Device Recall ALTRUA 2 EL DR Pacemaker
  • Figure 3 43: Class 2 Device Recall ALTRUA 2 SR Pacemaker
  • Figure 3 44: Class 2 Device Recall ALTRUA 2 DR Pacemaker
  • Figure 3 45: Class 2 Device Recall Accolade MRI and Essentio MRI pacemakers
  • Figure 3 46: Class 2 Device Recall Implantable Cardioverter Defibrillator (NonCRT)
  • Figure 3 47: Class 2 Device Recall RESONATE EL ICD VR
  • Figure 3 48: Class 2 Device Recall RESONATE EL ICD DR
  • Figure 3 49: Class 2 Device Recall EMBLEM SICD, Model A209
  • Figure 3 50: Class 2 Device Recall SQRX 1010 Pulse Generator
  • Figure 3 51: Class 2 Device Recall EMBLEM MRI SICD Model 219
  • Figure 3 52: Class 2 Device Recall SQRX Model 1010 Subcutaneous Pulse Generator
  • Figure 3 53: Class 2 Device Recall VISIONIST X4 CRTP (Cardiac Resynchronization Therapy Pacemaker)
  • Figure 3 54: Class 2 Device Recall VALITUDE X4 CRTP (Cardiac Resynchronization Therapy Pacemaker)
  • Figure 3 55: Class 2 Device Recall VALITUDE X4 CRTP Pacemaker
  • Figure 3 56: Class 2 Device Recall VALITUDE CRTP Pacemaker
  • Figure 3 57: Class 2 Device Recall VISIONIST X4 CRTP Pacemaker
  • Figure 3 58: Class 2 Device Recall VISIONIST CRTP Pacemaker
  • Figure 3 59: Class 2 Device Recall VALITUDE X4 CRTP Pacemaker
  • Figure 3 60: Class 2 Device Recall RESONATE X4 CRTD
  • Figure 3 61: Class 2 Device Recall MOMENTUM X4 CRTD
  • Figure 3 62: Class 2 Device Recall VIGILANT X4 CRTD
  • Figure 3 63: Class 2 Device Recall Boston Scientific, INGEVITY MRI Leads, Sterile EO, RxOnly
  • Figure 3 64: Class 2 Device Recall Maestro 4000 Cardiac Ablation System
  • Figure 3 65: Class 2 Device Recall CLEARSIGN II Amplifier for LABSYSTEM PRO EP Recording System
  • Figure 3 66: Class 3 Device Recall Cardiac Ablation Percutaneous Catheters
  • Figure 3 67: Class 1 Device Recall Intella Tip MiFi Open Irrigated Ablation Catheter
  • Figure 3 68: Class 2 Device Recall 9131 Defibrillator Electrodes
  • Figure 3 69: Class 2 Device Recall Medtronic Model 53401 Single Chamber External Pulse Generator
  • Figure 3 70: Class 2 Device Recall Medtronic Model 5392 Dual Chamber Temporary External Pulse Generator
  • Figure 3 71: Class 2 Device Recall EnTrust Dual Chamber Implantable Cardioverter Defibrillator with Atrial and Ventricular Therapies
  • Figure 3 72: Class 2 Device Recall EnTrust Single Chamber Implantable Cardioverter Defibrillator with Atrial and Ventricular Therapies
  • Figure 3 73: Class 2 Device Recall Medtronic EnTrust Escudo
  • Figure 3 74: Class 1 Device Recall Evera MRI XT DR ICD, Evera MRI XT VR ICD, Evera MRI S DR ICD
  • Figure 3 75: Class 1 Device Recall Visia AF MRI VR SureScan ICD
  • Figure 3 76: Class 1 Device Recall Visia AF VR ICD
  • Figure 3 77: Class 1 Device Recall Evera S DR ICD, Evera S VR ICD, Evera XT DR ICD, Evera XT VR ICD
  • Figure 3 78: Class 2 Device Recall Evera ICD
  • Figure 3 79: Class 2 Device Recall Viva ICD
  • Figure 3 80: Class 2 Device Recall Percepta CRTP MRI SureScan
  • Figure 3 81: Class 2 Device Recall Percepta Quad CRTP MRI SureScan
  • Figure 3 82: Class 1 Device Recall Amplia MRI CRTD, Amplia MRI Quad CRTD
  • Figure 3 83: Class 1 Device Recall Viva Quad S CRTD, Viva Quad XT CRTD, Viva S CRTD, Viva XT CRTD
  • Figure 3 84: Class 1 Device Recall Compia MRI CRTD, Compia MRI Quad CRTD
  • Figure 3 85: Class 2 Device Recall Amplia MRI Quad CRT0 SureScanClaria MRI Quad CRTD SureScanCompia MRI Quad CRTD SureScan
  • Figure 3 86: Class 2 Device Recall InSync III
  • Figure 3 87: Class 2 Device Recall Medtronic, Temporary Pacing Lead System
  • Figure 3 88: Class 2 Device Recall Achieve Electrical Cable
  • Figure 3 89: Class 2 Device Recall Medtronic CryoConsole
  • Figure 3 90: Class 2 Device Recall Platinium DR 1510
  • Figure 3 91: Class 2 Device Recall Platinium VR 1210
  • Figure 3 92: Class 2 Device Recall Platinium DR DF4 1540
  • Figure 3 93: Class 2 Device Recall Platinium VR DF4 1240
  • Figure 3 94: Class 2 Device Recall PARADYM
  • Figure 3 95: Class 2 Device Recall OVATIO
  • Figure 3 96: Class 2 Device Recall INTENSIA
  • Figure 3 97: Class 2 Device Recall Platinium Implantable Cardiac Defibrillator and Resynchronization Therapy Defibrillator
  • Figure 3 98: Class 2 Device Recall Platinium CRTD 1741
  • Figure 3 99: Class 2 Device Recall Platinium CRT DF1 1711
  • Figure 3 100: Class 2 Device Recall PARADYM
  • Figure 3 101: Class 2 Device Recall OVATIO
  • Figure 3 102: Class 2 Device Recall INTENSIA
  • Figure 3 103: Class 2 Device Recall HeartStart MRx Monitor/Defibrillator
  • Figure 3 104: Class 2 Device Recall Philips HeartStart FRx AED
  • Figure 3 105: Class 2 Device Recall Philips HeartStart (HS1) (Onsite/Home) AED
  • Figure 3 106: Class 3 Device Recall XL Defibrillator
  • Figure 3 107: Class 2 Device Recall Philips QCPR Meter CPR feedback device
  • Figure 3 108: Class 2 Device Recall HeartStart MRx Monitor/Defibrillator
  • Figure 3 109: Class 2 Device Recall Philips HeartStart
  • Figure 3 110: Class 2 Device Recall BW Lasso 2515 ANV eco Variable Diagnostic EP Catheter
  • Figure 3 111: Class 2 Device Recall Reprocessed LASSO NAV eco Electrophysiology Catheter
  • Figure 3 112: Class 2 Device Recall Reprocessed Coronary Sinus Diagnostic EP Catheter
  • Figure 3 113: Class 2 Device Recall Stryker Sustainability Solutions Reprocessed BW Lasso 2515 NAV eco Variable Diagnostic
  • Figure 3 114: Class 2 Device Recall Stryker Sustainability Solutions
  • Figure 3 115: Class 2 Device Recall Daig Livewire Steerable and Supreme Fixed Curve Diagnostic Electrophysiology Catheters
  • Figure 3 116: Class 2 Class 2 Device Recall OneStep CPR Complete
  • Figure 3 117: Class 2 Device Recall LifeVest Wearable Defibrillator
  • Figure 3 118: SJM Brady MRI Post Approval Study
  • Figure 3 119: Evaluation of Atrial Fibrillation Occurrence in Sick Sinus and Complete Atrioventricular Block Patients After Pacemaker Implantation (AF-pacemaker Study)
  • Figure 3 120: Longitudinal Coverage With Evidence Development Study on Micra Leadless Pacemakers
  • Figure 3 121: Heart Failure Indication and Sudden Cardiac Death Prevention Trial Japan
  • Figure 3 122: BIO|MASTER.Edora Family Study
  • Figure 3 123: China Micra Transcatheter Pacing Study
  • Figure 3 124: Optimizing Pacemaker Therapy Using Multi-Point Pacing (the OPT-MPP Study)
  • Figure 3 125: Cardioversion, Ablation or Pace and Ablate for Persistent Atrial Fibrillation in Over 65s - The CAPAPAF-65 Study
  • Figure 3 126: Advanced Bradycardia Device Feature Utilization and Clinical Outcomes II
  • Figure 3 127: Observation of ImageReady™ MR Conditional Pacing System in China
  • Figure 3 128: Micra Transcatheter Pacing System Continued Access Study Protocol
  • Figure 3 129: Comparison of CRT-D and CRT-DX Systems (CRT-NEXT)
  • Figure 3 130: Increasing Detection of Sub-Clinical Atrial Fibrillation in Defibrillator Patients with the Use of a VDD-ICD Lead (Dx-AF)
  • Figure 3 131: Multicenter Automatic Defibrillator Implantation Trial with Subcutaneous Implantable Cardioverter Defibrillator (MADIT S-ICD)
  • Figure 3 132: Extravascular ICD Pilot Study
  • Figure 3 133: Acute Feasibility Investigation of a New S-ICD Electrode Arrangement for Reduction of Defibrillation Energies
  • Figure 3 134: Subcutaneous ICD Therapy Combined with VT Ablation for the Secondary Prevention of Sudden Cardiac Death
  • Figure 3 135: BIO|MASTER.Ilivia Family/Plexa
  • Figure 3 136: The REACT-ICD Trial (REACT-ICD)
  • Figure 3 137: Prospective Randomized Trial Comparing TRIPLE Site ventricular Stimulation Versus Conventional Pacing in CRT candidates: TRIPLEAD Trial
  • Figure 3 138: Can Cognitive Function be Improved by Cardiac Resynchronization Therapy? (COGNI-CRT)
  • Figure 3 139: Re-evaluation of Optimal Re-synchronization Therapy in Patients with Chronic Heart Failure - An Investigator-driven, Prospective, Parallel-group, Randomized, Open, Blinded Outcome Assessment (PROBE), Multi-center Trial Without Investigational Medical Products (Proof of Strategy Trial)
  • Figure 3 140: Continued Access Clinical Trial of the SonRtip Lead and Automatic AV-VV Optimization Algorithm in the Paradym RF SonR CRT-D
  • Figure 3 141: AV Optimization Delivered with Direct His Bundle Pacing, in Patients with Heart Failure, Long PR Without Left Bundle Branch Block: Randomized Multi-center Clinical Outcome Study.
  • Figure 3 142: Heart Failure with Preserved Ejection Fraction Treated by Cardiac Resynchronization Therapy Versus Rate Responsive Pacing: A Mechanistic Study
  • Figure 3 143: Cardiac Resynchronization in the Elderly: Piloting Pacemaker vs. Defibrillator Therapy (Randomized Trial)
  • Figure 3 144: Assessment of Pacing Stimulus Conduction and Latency Measurements in CRT-D Patients (BIO|PULSE)
  • Figure 3 145: A Multicentre Randomized Control Trial Comparing Standard Cardiac Resynchronization Pacing with Triventricular Pacing
  • Figure 3 146: Responders and Quadripolar LV Lead in CRT
  • Figure 3 147: Does Targeted LV Lead Positioning Towards Latest Local Electric Activation at CRT Implantation Reduce Incidence of the Combined Endpoint "Death or Non-planned Hospitalization for Heart Failure (HF)" in Patients with HF and Prolonged QRS
  • Figure 3 148: Plexa ICD Lead Registry
  • Figure 3 149: AXONE -Acute: Safety and Electrical Performance Evaluation of INVICTA Leads Models Equipped with DF4 Connector
  • Figure 3 150: Safety and Electrical Performances Evaluation of Navigo Leads Equipped with IS4 Connector (NAVIGATOR)
  • Figure 3 151: Avoid Transvenous Leads in Appropriate Subjects
  • Figure 3 152: Left Ventricular Septal Pacing: Potential Application for Cardiac Resynchronization Therapy
  • Figure 3 153: Quartet Lead and Resynchronization Therapy Options - Assessing the Response Rate at 6 Months in CRT Patients Implanted with a Quartet Left Ventricular (LV) Quadripolar Lead and the MultiPoint Pacing (MPP) Feature Activated
  • Figure 3 154: Attain Stability™ Quad Clinical Study
  • Figure 3 155: Imaging Study of Lead Implant for His Bundle Pacing ((IMAGE-HBP))
  • Figure 3 156: The Efficacy of Single Coil Defibrillation Leads for Internal Cardioversion of Persistent Atrial Fibrillation
  • Figure 3 157: Reverse RAMP Pacing to Terminate Ventricular Tachycardia (REV-RAMP)
  • Figure 3 158: AXONE -Acute: Acute Assessment of a Micro Multipolar Lead for Enhanced Cardiac Resynchronization Therapy
  • Figure 3 159: A Clinical Evaluation of the Durata or Optisure High Voltage Leads and Ellipse VR ICD Undergoing Magnetic Resonance Imaging, an Investigational Device Exemption (IDE) Study
  • Figure 3 160: Acute Extravascular Defibrillation Study
  • Figure 3 161: Quality of Cardiopulmonary Resuscitation Guided by AED vs Telephone-assistance
  • Figure 3 162: Accuracy of Instructional Diagrams for Automated External Defibrillator (AED) Pad Positioning
  • Figure 3 163: RHythmia mAPping and Signal acquisitiOn for Data analYsis (RHAPSODY)
  • Figure 3 164: Esophageal 3D Mapping System for Cardiac Arrhythmias: Pilot Study to Establish Basis for Improved Arrhythmia Diagnostics Using the esoECG-3D Catheter
  • Figure 3 165: Real-time Electrogram Analysis for Drivers of AtRial Fibrillation (RADAR)
  • Figure 3 166: EnSite™ HD Grid Catheter Mapping System for Advanced High Density Three-Dimensional Mapping in Non-Paroxysmal Atrial Fibrillation and Atrial Tachycardia
  • Figure 3 167: Clinical Utility and Validation of the Rhythmia Mapping System for the Treatment of Cardiac Arrhythmias
  • Figure 3 168: Surface ECG Signal Recording for the Implantable Subcutaneous String Defibrillator (ISSD) Detection Algorithm Performance Assessment
  • Figure 3 169: Surface Electrocardiogram (ECG) Signal Recording for Implantable Subcutaneous String Defibrillator (ISSD) Development
  • Figure 3 170: Advanced Cardiac Therapeutics DiamondTemp TempeRAture-Controlled and Contact Sensing RF Ablation Clinical Trial for Atrial Fibrillation
  • Figure 3 171: Visualization of Human Cardiovascular Anatomy With Foresight Intracardiac Echocardiography (ICE) System
  • Figure 3 172: INtra-procedural ultraSound Imaging for DEtermination of Atrial Wall Thickness and Acute Tissue Changes During Isolation of the Pulmonary Veins
  • Figure 3 173: EnSite Precision™ Cardiac Mapping System and EnSite Precision™ Software v2.0 Observational Registry
  • Figure 3 174: Visualization of Human Cardiovascular Anatomy With Foresight Intracardiac Echocardiography (ICE) System
  • Figure 3 175: Esophageal 3D Mapping System for Cardiac Arrhythmias: Pilot Study to Establish Basis for Improved Arrhythmia Diagnostics Using the esoECG-3D Catheter
  • Figure 3 176: EnSite™ HD Grid Catheter Mapping System for Advanced High Density Three-Dimensional Mapping in Non-Paroxysmal Atrial Fibrillation and Atrial Tachycardia
  • Figure 3 177: DURABLE-I Study: Dielectric Unravelling of Radiofrequency ABLation Effectiveness
  • Figure 3 178: FIRE AND ICE II Trial Pilot
  • Figure 3 179: Safety and Effectiveness Evaluation of the Multi-Electrode Radiofrequency Balloon Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation (STELLAR)
  • Figure 3 180: Clinical Study for Safety and Acute Performance Evaluation of the THERMOCOOL SMARTTOUCH® SF-5D System Used With Fast Ablation Mode in Treatment of Patients With Paroxysmal Atrial Fibrillation
  • Figure 3 181: Microfidelity (MIFI) Ablation Technology Versus Standard Ablation Catheter for Atrioventricular Nodal Ablation A Comparative Pilot Study of Time to Success
  • Figure 3 182: Cardiovascular Magnetic Resonance-Guided Radiofrequency-Ablation for Atrial Flutter
  • Figure 3 183: Advanced Cardiac Therapeutics DiamondTemp TempeRAture-Controlled and Contact Sensing RF Ablation Clinical Trial for Atrial Fibrillation
  • Figure 3 184: Feasibility Study for Optically Guided Radiofrequency Ablation Catheter
  • Figure 3 185: CRyoAblation vs AntiaRrhythmic Drugs for Persistent Atrial Fibrillation Trial
  • Figure 3 186: Cryoballoon Pulmonary Vein Isolation as First Line Treatment for Typical Atrial Flutter
  • Figure 3 187: ArcticLine Feasibility Study
  • Figure 3 188: A Prospective, Multicenter Investigation of the Adagio Cryoablation System in Patients With Atrial Fibrillation
  • Figure 3 189: A Prospective Study of Medical Therapy Against Cryoballoon Ablation in Symptomatic Recent Onset Persistent Atrial Fibrilation
  • Figure 3 190: STOP AF First: Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation
  • Figure 3 191: CoolLoop Paroxysmal Atrial Fibrillation
  • Figure 3 192: A Comparison of Radiofrequency Catheter Ablation With or Without Contact-force and Cryoablation for Paroxysmal Atrial Fibrillation Ablation
  • Figure 3 193: A Prospective, Multicenter, Investigation of the Adagio PolarStar System in Subjects With Atrial Flutter
  • Figure 3 194: PV Cryoablation Efficacy Using Electrophysiological Endpoints and the New Generation ArticFont Advance ST Catheter (COR ADVANCE Study)
  • Figure 3 195: Left Atrial Cryoablation Enhanced by Ganglionated Plexi Ablation in the Treatment of Atrial Fibrillation
  • Figure 3 196: Cryterion Cardiac Cryoablation System First in Man Clinical Study
  • Figure 3 197: STOP Persistent AF
  • Figure 3 198: Cryoablation of Atrial Fibrillation in Patients With Severe Heart Failure
  • Figure 3 199: PV Cryoablation Efficacy Using Electrophysiological Endpoints and the New Generation ArticFont Advance ST Catheter (COR ADVANCE Study)
  • Figure 3 200: CardioFocus vs. Contact Force Guided Pulmonary Vein Isolation in Paroxysmal Atrial Fibrillation
  • Figure 3 201: Laser Ablation Study for trEatment of atRial Fibrillation (LASER)
  • Figure 3 202: A Clinical Trial for the Assessment of the Safety and Performance of the Vimecon Laser Cardiac Ablation Instrument (CAI) for the Interventional Treatment of Paroxysmal Atrial Fibrillation (AF)
  • Figure 4 1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, U.S., 2015 - 2025 (US$M) (1 of 2)
  • Figure 4 2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, U.S., 2015 - 2025 (US$M) (2 of 2)
  • Figure 4 3: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Growth by Segment, U.S., 2015 - 2025 (1 of 2)
  • Figure 4 4: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Growth by Segment, U.S., 2015 - 2025 (2 of 2)
  • Figure 4 5: Drivers and Limiters, Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, U.S., 2018
  • Figure 4 6: Leading Competitors, Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, U.S., 2018 (1 of 2)
  • Figure 4 7: Leading Competitors, Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, U.S., 2018 (2 of 2)
  • Figure 4 8: SWOT Analysis, Abbott (1 of 2)
  • Figure 4 9: SWOT Analysis, Abbott (2 of 2)
  • Figure 4 10: SWOT Analysis, Biosense Webster
  • Figure 4 11: SWOT Analysis, Biotronik
  • Figure 4 12: SWOT Analysis, Boston Scientific
  • Figure 4 13: SWOT Analysis, Cardiac Science
  • Figure 4 14: SWOT Analysis, GE Healthcare
  • Figure 4 15: SWOT Analysis, Medtronic
  • Figure 4 16: SWOT Analysis, MicroPort (1 of 2)
  • Figure 4 17: SWOT Analysis, MicroPort (2 of 2)
  • Figure 4 18: SWOT Analysis, ZOLL
  • Figure 5 1: Procedure Codes Investigated, U.S., 2018
  • Figure 5 2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Procedures by Type, U.S., 2015 - 2025 (1 of 2)
  • Figure 5 3: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Procedures by Type, U.S., 2015 - 2025 (2 of 2)
  • Figure 6 1: Pacemaker Market by Segment, U.S., 2015 - 2025 (US$M)
  • Figure 6 2: Total Pacemaker Market, U.S., 2015 - 2025
  • Figure 6 3: Single-Chamber Pacemaker Market by Segment, U.S., 2015 - 2025 (US$M)
  • Figure 6 4: Total Single-Chamber Pacemaker Market, U.S., 2015 - 2025
  • Figure 6 5: Initial Placement Single-Chamber Pacemaker Market, U.S., 2015 - 2025
  • Figure 6 6: Replacement Single-Chamber Pacemaker Market, U.S., 2015 - 2025
  • Figure 6 7: Dual-Chamber Pacemaker Market by Segment, U.S., 2015 - 2025 (US$M)
  • Figure 6 8: Total Dual-Chamber Pacemaker Market, U.S., 2015 - 2025
  • Figure 6 9: Initial Placement Dual-Chamber Pacemaker Market, U.S., 2015 - 2025
  • Figure 6 10: Replacement Dual-Chamber Pacemaker Market, U.S., 2015 - 2025
  • Figure 6 11: Leadless Pacemaker Market, U.S., 2015 - 2025
  • Figure 6 12: Pricing Tiers, Pacemaker Market, U.S., 2018
  • Figure 6 13: Drivers and Limiters, Pacemaker Market, U.S., 2018
  • Figure 6 14: Leading Competitors, Pacemaker Market, U.S., 2018
  • Figure 7 1: ICD Market by Segment, U.S., 2015 - 2025 (US$M)
  • Figure 7 2: Total ICD Market, U.S., 2015 - 2025
  • Figure 7 3: Single-Chamber ICD Market by Segment, U.S., 2015 - 2025 (US$M)
  • Figure 7 4: Total Single-Chamber ICD Market, U.S., 2015 - 2025
  • Figure 7 5: Initial Placement Single-Chamber ICD Market, U.S., 2015 - 2025
  • Figure 7 6: Replacement Single-Chamber ICD Market, U.S., 2015 - 2025
  • Figure 7 7: Dual-Chamber ICD Market by Segment, U.S., 2015 - 2025 (US$M)
  • Figure 7 8: Total Dual-Chamber ICD Market, U.S., 2015 - 2025
  • Figure 7 9: Initial Placement Dual-Chamber ICD Market, U.S., 2015 - 2025
  • Figure 7 10: Replacement Dual-Chamber ICD Market, U.S., 2015 - 2025
  • Figure 7 11: S-ICD Market, U.S., 2015 - 2025
  • Figure 7 12: Drivers and Limiters, ICD Market, U.S., 2018
  • Figure 7 13: Leading Competitors, ICD Market, U.S., 2018
  • Figure 8 1: Cardiac Resynchronization Therapy Device Market by Segment, U.S., 2015 - 2025 (US$M)
  • Figure 8 2: Total CRT Market, U.S., 2015 - 2025
  • Figure 8 3: CRT-P Market by Segment, U.S., 2015 - 2025 (US$M)
  • Figure 8 4: Total CRT-P Market, U.S., 2015 - 2025
  • Figure 8 5: Initial Placement CRT-P Market, U.S., 2015 - 2025
  • Figure 8 6: Replacement CRT-P Market, U.S., 2015 - 2025
  • Figure 8 7: CRT-D Market by Segment, U.S., 2015 - 2025 (US$M)
  • Figure 8 8: Total CRT-D Market, U.S., 2015 - 2025
  • Figure 8 9: Initial Placement CRT-D Market, U.S., 2015 - 2025
  • Figure 8 10: Replacement CRT-D Market, U.S., 2015 - 2025
  • Figure 8 11: Drivers and Limiters, CRT Market, U.S., 2018
  • Figure 8 12: Leading Competitors, CRT Market, U.S., 2018
  • Figure 9 1: Cardiac Lead Market by Segment, U.S., 2015 - 2025 (US$M)
  • Figure 9 2: Total Cardiac Lead Market, U.S., 2015 - 2025
  • Figure 9 3: Pacing Lead Market, U.S., 2015 - 2025
  • Figure 9 4: Defibrillation Lead Market, U.S., 2015 - 2025
  • Figure 9 5: LV Lead Market, U.S., 2015 - 2025
  • Figure 9 6: Drivers and Limiters, Cardiac Lead Market, U.S., 2018
  • Figure 9 7: Leading Competitors, Cardiac Lead Market, U.S., 2018
  • Figure 10 1: Electrocardiography Monitoring Market by Segment, U.S., 2015 - 2025 (US$M)
  • Figure 10 2: Resting ECG Device Market by Segment, U.S., 2015 - 2025 (US$M)
  • Figure 10 3: Total Resting ECG Device Market, U.S., 2015 - 2025
  • Figure 10 4: Hospital-Based Resting ECG Device Market, U.S., 2015 - 2025
  • Figure 10 5: Office-Based Resting ECG Device Market by Segment, U.S., 2015 - 2025 (US$M)
  • Figure 10 6: Total Office-Based Resting ECG Device Market, U.S., 2015 - 2025
  • Figure 10 7: Purpose-Built Office-Based Resting ECG Device Market, U.S., 2015 - 2025
  • Figure 10 8: PC-Based Office-Based Resting ECG Device Market, U.S., 2015 - 2025
  • Figure 10 9: Stress Testing Device Market by Segment, U.S., 2015 - 2025 (US$M)
  • Figure 10 10: Total Stress Testing Device Market, U.S., 2015 - 2025
  • Figure 10 11: Hospital-Based Stress Testing Device Market, U.S., 2015 - 2025
  • Figure 10 12: Office-Based Stress Testing Device Market, U.S., 2015 - 2025
  • Figure 10 13: Holter Monitoring Recorder Market by Segment, U.S., 2015 - 2025 (US$M)
  • Figure 10 14: Total Holter Monitoring Recorder Market, U.S., 2015 - 2025
  • Figure 10 15: Hospital-Based Holter Monitoring Recorder Market, U.S., 2015 - 2025
  • Figure 10 16: Office-Based Holter Monitoring Recorder Market, U.S., 2015 - 2025
  • Figure 10 17: IDTF Holter Monitoring Recorder Market, U.S., 2015 - 2025
  • Figure 10 18: Drivers and Limiters, Electrocardiography Monitoring Market, U.S., 2018
  • Figure 10 19: Leading Competitors, Electrocardiography Monitoring Market, U.S., 2018
  • Figure 11 1: Lab Systems Market by Segment, U.S., 2015 - 2025 (US$M)
  • Figure 11 2: 3D Mapping Market, U.S., 2015 - 2025
  • Figure 11 3: EP Recording Market, U.S., 2015 - 2025
  • Figure 11 4: RF Ablation Generator Market, U.S., 2015 - 2025
  • Figure 11 5: Remote Steering System Market, U.S., 2015 - 2025
  • Figure 11 6: Drivers and Limiters, Lab Systems Market, U.S., 2018
  • Figure 11 7: Leading Competitors, Lab Systems Market, U.S., 2018 (1 of 2)
  • Figure 12 1: Diagnostic Electrophysiology Catheters Market by Segment, U.S., 2015 - 2025 (US$M)
  • Figure 12 2: Total Diagnostic Electrophysiology Catheters Market, U.S., 2015 - 2025
  • Figure 12 3: EP Conventional Catheter Market by Segment, U.S., 2015 - 2025 (US$M)
  • Figure 12 4: Total EP Conventional Catheter Market, U.S., 2015 - 2025
  • Figure 12 5: Fixed EP Catheter Market, U.S., 2015 - 2025
  • Figure 12 6: Steerable EP Catheter Market, U.S., 2015 - 2025
  • Figure 12 7: EP Advanced Catheter Market, U.S., 2015 - 2025
  • Figure 12 8: ICE Diagnostic Catheter Market, U.S., 2015 - 2025
  • Figure 12 9: Drivers and Limiters, Diagnostic Electrophysiology Catheters Market, U.S., 2018
  • Figure 12 10: Leading Competitors, Diagnostic Electrophysiology Catheters Market, U.S., 2018
  • Figure 13 1: Cardiac Ablation Catheter Market by Segment, U.S., 2015 - 2025 (US$M)
  • Figure 13 2: Cardiac Ablation Catheter Market, U.S., 2015 - 2025
  • Figure 13 3: RF Ablation Catheter Market by Segment, U.S., 2015 - 2025 (US$M)
  • Figure 13 4: Total RF Ablation Catheter Market, U.S., 2015 - 2025
  • Figure 13 5: Irrigated RF Ablation Catheter Market, U.S., 2015 - 2025
  • Figure 13 6: Non-Irrigated RF Ablation Catheter Market, U.S., 2015 - 2025
  • Figure 13 7: Cryoablation Catheter Market, U.S., 2015 - 2025
  • Figure 13 8: Drivers and Limiters, Cardiac Ablation Catheter Market, U.S., 2018
  • Figure 13 9: Leading Competitors, Cardiac Ablation Catheter Market, U.S., 2018
  • Figure 14 1: ICE Generator Market, U.S., 2015 - 2025
  • Figure 14 2: Drivers and Limiters, ICE Generator Market, U.S., 2018
  • Figure 14 3: Leading Competitors, ICE Generator Market, U.S., 2018
  • Figure 15 1: Cryoablation Generator Market, U.S., 2015 - 2025
  • Figure 15 2: Drivers and Limiters, Cryoablation Generator Market, U.S., 2018
  • Figure 16 1: External Defibrillator Market by Segment, U.S., 2015 - 2025 (US$M)
  • Figure 16 2: Total External Defibrillator Market, U.S., 2015 - 2025
  • Figure 16 3: Automated External Defibrillator Market, U.S., 2015 - 2025
  • Figure 16 4: Wearable Cardioverter Defibrillator Market, U.S., 2015 - 2025
  • Figure 16 5: Drivers and Limiters, External Defibrillator Market, U.S., 2018
  • Figure 16 6: Leading Competitors, External Defibrillator Market, U.S., 2018
目次
Product Code: iDATA_USCRMEP19_MS

This report on cardiac rhythm management (CRM) devices analyzes the market for medical devices used for diagnosing and treating cardiac arrhythmias. The medical device markets included in this report are pacemakers, implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy devices (CRTs), cardiac stimulation leads, electrocardiogram monitoring (ECGs), external defibrillators, electrophysiology (EP) lab systems, diagnostic electrophysiology (EP) catheters and cardiac ablation catheters.

In 2018, the total market for cardiac rhythm management, electrophysiology and ablation devices experienced an increase over the previous year. Since these devices are critical life-saving apparatuses, the aging U.S. population means continued market growth for all market segments in this report, with particularly strong growth in the electrophysiology (EP) and ablation markets.

TABLE OF CONTENTS

TABLE OF CONTENTS

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

U.S. CARDIAC RHYTHM MANAGEMENT, ELECTROPHYSIOLOGY & CARDIAC ABLATION MARKET OVERVIEW

COMPETITIVE ANALYSIS

MARKET TRENDS

MARKET DEVELOPMENTS

PROCEDURE NUMBERS

PROCEDURE CODES INVESTIGATED

MARKETS INCLUDED

KEY REPORT UPDATES

VERSION HISTORY

RESEARCH METHODOLOGY

  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems and Perform Secondary Research
  • Step 3: Preparation for Interviews & Questionnaire Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecast and Analysis
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review and Market Release
  • Step 9: Customer Feedback and Market Monitoring

DISEASE OVERVIEW

  • 2.1 INTRODUCTION
  • 2.2 TYPES OF ARRHYTHMIAS
    • 2.2.11 Atrial Fibrillation
    • 2.2.12 Bradycardia
    • 2.2.13 Conduction Disorders
      • 2.2.13.1 Bundle Branch Block
      • 2.2.13.2 Heart Block
      • 2.2.13.3 Long QT Syndrome (LQTS)
    • 2.2.14 Premature Contractions: PACs and PVCs
    • 2.2.15 Tachycardia
    • 2.2.16 Ventricular Fibrillation
    • 2.2.17 Other Rhythm Disorders
      • 2.2.17.1 Adams-Stokes Disease
      • 2.2.17.2 Atrial Flutter
      • 2.2.17.3 Sick Sinus syndrome
      • 2.2.17.4 Sinus Arrhythmia
      • 2.2.17.5 Wolff-Parkinson-White Syndrome (WPW)
    • 2.2.18 Types of Arrhythmia in Children
  • 2.3 HEART FAILURE
  • 2.4 CARDIAC ARREST
  • 2.5 PATIENT DEMOGRAPHICS
    • 2.5.11 Atrial Fibrillation
    • 2.5.12 Bradycardia
    • 2.5.13 Conduction Disorders
    • 2.5.14 Premature Contractions - PACs and PVCs
    • 2.5.15 Tachycardia
    • 2.5.16 Ventricular Fibrillation
    • 2.5.17 Other Rhythm Disorders

PRODUCT ASSESSMENT

  • 3.1 INTRODUCTION
  • 3.2 PRODUCT PORTFOLIOS
    • 3.2.1 Pacemakers
    • 3.2.2 Implantable Cardioverter Defibrillators (ICDs)
    • 3.2.3 Cardiac Resynchronization Therapy (CRT) Devices
    • 3.2.4 Cardiac Leads
    • 3.2.5 External Defibrillators
    • 3.2.6 Lab Systems
      • 3.2.6.1 Introduction
      • 3.2.6.2 3D Mapping Systems
      • 3.2.6.3 EP Recording Systems
      • 3.2.6.4 Remote Steering Systems
      • 3.2.6.5 RF Ablation Generator
      • 3.2.6.6 ICE Systems
      • 3.2.6.7 Product Matrix for Lab Systems: Core Companies
    • 3.2.7 Diagnostic EP Catheters
      • 3.2.7.1 Introduction
      • 3.2.7.2 Diagnostic EP Catheters
      • 3.2.7.3 ICE Catheters
    • 3.2.8 Cardiac Ablation Catheters
      • 3.2.8.1 Introduction
      • 3.2.8.2 RF Ablation Catheters
      • 3.2.8.3 Alternative Energy Catheters
      • 3.2.8.4 High Intensity Focused Ultrasound
  • 3.3 FDA RECALLS
    • 3.3.1 Abbott
      • 3.3.1.1 Pacemakers
      • 3.3.1.2 Implantable Cardioverter Defibrillators (ICDs)
      • 3.3.1.3 Cardiac Resynchronization Therapy (CRT) Devices
      • 3.3.1.4 Cardiac Leads
      • 3.3.1.5 EP Lab Devices
      • 3.3.1.6 Cardiac Ablation Catheter
    • 3.3.2 Biosense Webster
      • 3.3.2.1 EP Lab Devices
    • 3.3.3 Boston Scientific
      • 3.3.3.1 Pacemakers
      • 3.3.3.2 Implantable Cardioverter Defibrillators (ICDs)
      • 3.3.3.3 Cardiac Resynchronization Therapy (CRT) Devices
      • 3.3.3.4 Cardiac Leads
      • 3.3.3.5 EP Lab Devices
      • 3.3.3.6 RF Ablation Catheter
    • 3.3.4 Cardiac Science
      • 3.3.4.1 Automated External Defibrillator (AED)
    • 3.3.5 Medtronic
      • 3.3.5.1 Pacemakers
      • 3.3.5.2 Implantable Cardioverter Defibrillators (ICDs)
      • 3.3.5.3 Cardiac Resynchronization Therapy (CRT) Devices
      • 3.3.5.4 Cardiac Leads
      • 3.3.5.5 EP Lab Devices
    • 3.3.6 MicroPort
      • 3.3.6.1 Implantable Cardioverter Defibrillators (ICDs)
      • 3.3.6.2 Cardiac Resynchronization Therapy (CRT) Devices
    • 3.3.7 Philips Healthcare
      • 3.3.7.1 Automated External Defibrillator (AED)
    • 3.3.8 Stryker Sustainability Solutions
      • 3.3.8.1 Diagnostic EP Catheters
    • 3.3.9 ZOLL
      • 3.3.9.1 Automated External Defibrillator (AED)
      • 3.3.9.2 Wearable Cardioverter Defibrillator (WCD)
  • 3.4 CLINICAL TRIALS
    • 3.4.1 Pacemakers
    • 3.4.2 Implantable Cardioverter Defibrillators (ICDs)
    • 3.4.3 Cardiac Resynchronization Therapy (CRT) Devices
    • 3.4.4 Cardiac Leads
    • 3.4.5 External Defibrillators
    • 3.4.6 Lab Systems
      • 3.4.6.1 3D Mapping Systems
      • 3.4.6.2 EP Recording Systems
      • 3.4.6.3 RF Ablation Generators
      • 3.4.6.4 ICE Systems
    • 3.4.7 Diagnostic EP Catheters
      • 3.4.7.1 Diagnostic Catheter
    • 3.4.8 Cardiac Ablation Catheter
      • 3.4.8.1 RF Ablation Catheters
      • 3.4.8.2 Cryoablation Catheters
      • 3.4.8.3 Laser Ablation Catheters

U.S. CARDIAC RHYTHM MANAGEMENT, ELECTROPHYSIOLOGY & CARDIAC ABLATION MARKET OVERVIEW

  • 4.1 INTRODUCTION
  • 4.2 MARKET OVERVIEW
  • 4.3 TREND ANALYSIS BY SEGMENT
  • 4.4 DRIVERS AND LIMITERS
    • 4.4.1 Market Drivers
    • 4.4.2 Market Limiters
  • 4.5 COMPETITIVE MARKET SHARE ANALYSIS
  • 4.6 MERGERS AND ACQUISITIONS
  • 4.7 COMPANY PROFILES
    • 4.7.1 Abbott
    • 4.7.2 Biosense Webster
    • 4.7.3 Biotronik
    • 4.7.4 Boston Scientific
    • 4.7.5 Cardiac Science
    • 4.7.6 GE Healthcare
    • 4.7.7 Medtronic
    • 4.7.8 MicroPort
    • 4.7.9 ZOLL
  • 4.8 SWOT ANALYSIS
    • 4.8.1 Abbott
    • 4.8.2 Biosense Webster
    • 4.8.3 Biotronik
    • 4.8.4 Boston Scientific
    • 4.8.5 Cardiac Science
    • 4.8.6 GE Healthcare
    • 4.8.7 Medtronic
    • 4.8.8 MicroPort
    • 4.8.9 ZOLL

PROCEDURE NUMBERS

  • 5.1 INTRODUCTION
  • 5.2 PROCEDURES
    • 5.2.1 Total Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Procedures

PACEMAKER MARKET

  • 6.1 INTRODUCTION
    • 6.1.1 Single and Dual-Chamber Devices
    • 6.1.2 MRI-Compatible Pacemaker
    • 6.1.3 Leadless Pacemaker
    • 6.1.4 Initial Placement and Replacement of Pacemakers
  • 6.2 MARKET OVERVIEW
  • 6.3 MARKET ANALYSIS AND FORECAST
    • 6.3.1 Total Pacemaker Market
    • 6.3.2 Total Single-Chamber Pacemaker Market
      • 6.3.2.1 Initial Placement Single-Chamber Pacemaker Market
      • 6.3.2.2 Replacement Single-Chamber Pacemaker Market
    • 6.3.3 Total Dual-Chamber Pacemaker Market
      • 6.3.3.1 Initial Placement Dual-Chamber Pacemaker Market
      • 6.3.3.2 Replacement Dual-Chamber Pacemaker Market
    • 6.3.4 Leadless Pacemaker Market
  • 6.4 PRICE ANALYSIS
  • 6.5 DRIVERS AND LIMITERS
    • 6.5.1 Market Drivers
    • 6.5.2 Market Limiters
  • 6.6 COMPETITIVE MARKET SHARE ANALYSIS

IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET

  • 7.1 INTRODUCTION
  • 7.2 MARKET OVERVIEW
  • 7.3 MARKET ANALYSIS AND FORECAST
    • 7.3.1 Total ICD Market
    • 7.3.2 Total Single-Chamber ICD Market
      • 7.3.2.1 Initial Placement Single-Chamber ICD Market
      • 7.3.2.2 Replacement Single-Chamber ICD Market
    • 7.3.3 Total Dual-Chamber ICD Market
      • 7.3.3.1 Initial Placement Dual-Chamber ICD Market
      • 7.3.3.2 Replacement Dual-Chamber ICD Market
    • 7.3.4 S-ICD Market
  • 7.4 DRIVERS AND LIMITERS
    • 7.4.1 Market Drivers
    • 7.4.2 Market Limiters
  • 7.5 COMPETITIVE MARKET SHARE ANALYSIS

CARDIAC RESYNCHRONIZATION THERAPY DEVICE MARKET

  • 8.1 INTRODUCTION
    • 8.1.1 Cardiac Resynchronization Therapy-Pacemakers (CRT-Ps)
    • 8.1.2 Cardiac Resynchronization Therapy-Defibrillators (CRT-Ds)
  • 8.2 MARKET OVERVIEW
  • 8.3 MARKET ANALYSIS AND FORECAST
    • 8.3.1 Total CRT Market
    • 8.3.2 Total CRT-P Market
      • 8.3.2.1 Initial Placement CRT-P Market
      • 8.3.2.2 Replacement CRT-P Market
    • 8.3.3 Total CRT-D Market
      • 8.3.3.1 Initial Placement CRT-D Market
      • 8.3.3.2 Replacement CRT-D Market
  • 8.4 DRIVERS AND LIMITERS
    • 8.4.1 Market Drivers
    • 8.4.2 Market Limiters
  • 8.5 COMPETITIVE MARKET SHARE ANALYSIS

CARDIAC LEADS MARKET

  • 9.1 INTRODUCTION
    • 9.1.1 Replacement of Leads
  • 9.2 MARKET OVERVIEW
  • 9.3 MARKET ANALYSIS AND FORECAST
    • 9.3.1 Total Cardiac Lead Market
    • 9.3.2 Pacing Lead Market
    • 9.3.3 Defibrillation Lead Market
    • 9.3.4 LV Lead Market
  • 9.4 DRIVERS AND LIMITERS
    • 9.4.1 Market Drivers
    • 9.4.2 Market Limiters
  • 9.5 COMPETITIVE MARKET SHARE ANALYSIS

ELECTROCARDIOGRAPHY MONITORING MARKET

  • 10.1 INTRODUCTION
    • 10.1.1 Holter Monitoring
    • 10.1.2 Stress Testing
  • 10.2 MARKET OVERVIEW
  • 10.3 MARKET ANALYSIS AND FORECAST
    • 10.3.1 Total Resting ECG Device Market
      • 10.3.1.1 Hospital-Based Resting ECG Device Market
      • 10.3.1.2 Total Office-Based Resting ECG Device Market
      • 10.3.1.2.1 Purpose-Built Office-Based Resting ECG Device Market
      • 10.3.1.2.2 PC-Based Office-Based Resting ECG Device Market
    • 10.3.2 Total Stress Testing Device Market
      • 10.3.2.1 Hospital-Based Stress Testing Device Market
      • 10.3.2.2 Office-Based Stress Testing Device Market
    • 10.3.3 Total Holter Monitoring Recorder Market
      • 10.3.3.1 Hospital-Based Holter Monitoring Recorder Market
      • 10.3.3.2 Office-Based Holter Monitoring Recorder Market
      • 10.3.3.3 IDTF Holter Monitoring Recorder Market
  • 10.4 DRIVERS AND LIMITERS
    • 10.4.1 Market Drivers
    • 10.4.2 Market Limiters
  • 10.5 COMPETITIVE MARKET SHARE ANALYSIS

LAB SYSTEMS MARKET

  • 11.1 INTRODUCTION
    • 11.1.1 3D Mapping Systems
    • 11.1.2 EP Recording Systems
    • 11.1.3 Remote Steering Systems
    • 11.1.4 RF Ablation Generator
    • 11.1.5 ICE System
  • 11.2 MARKET OVERVIEW
  • 11.3 MARKET ANALYSIS AND FORECAST
    • 11.3.1 3D Mapping Market
    • 11.3.2 EP Recording Market
    • 11.3.3 RF Ablation Generator Market
    • 11.3.4 Remote Steering System Market
  • 11.4 DRIVERS AND LIMITERS
    • 11.4.1 Market Drivers
    • 11.4.2 Market Limiters
  • 11.5 COMPETITIVE MARKET SHARE ANALYSIS

DIAGNOSTIC ELECTROPHYSIOLOGY CATHETERS MARKET

  • 12.1 INTRODUCTION
    • 12.1.1 Diagnostic Electrophysiology Catheters
    • 12.1.2 Reprocessed Catheters
    • 12.1.3 Intracardiac Echocardiography
  • 12.2 MARKET OVERVIEW
  • 12.3 MARKET ANALYSIS AND FORECAST
    • 12.3.1 Total Diagnostic Electrophysiology Catheters Market
    • 12.3.2 Total EP Conventional Catheter Market
      • 12.3.2.1 Fixed EP Catheter Market
      • 12.3.2.2 Steerable EP Catheter Market
    • 12.3.3 EP Advanced Catheter Market
    • 12.3.4 ICE Diagnostic Catheter Market
  • 12.4 DRIVERS AND LIMITERS
    • 12.4.1 Market Drivers
    • 12.4.2 Market Limiters
  • 12.5 COMPETITIVE MARKET SHARE ANALYSIS

CARDIAC ABLATION CATHETER MARKET

  • 13.1 INTRODUCTION
  • 13.2 MARKET OVERVIEW
  • 13.3 MARKET ANALYSIS AND FORECAST
    • 13.3.1 Cardiac Ablation Catheter Market
    • 13.3.2 RF Ablation Catheter Market
      • 13.3.2.1 Irrigated RF Ablation Catheter Market
      • 13.3.2.2 Non-Irrigated RF Ablation Catheter Market
    • 13.3.3 Cryoablation Catheter Market
  • 13.4 DRIVERS AND LIMITERS
    • 13.4.1 Market Drivers
    • 13.4.2 Market Limiters
  • 13.5 COMPETITIVE MARKET SHARE ANALYSIS

APPENDIX I: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) GENERATOR MARKET

  • 14.1 INTRODUCTION
  • 14.2 MARKET ANALYSIS AND FORECAST
  • 14.3 DRIVERS AND LIMITERS
    • 14.3.1 Market Drivers
    • 14.3.2 Market Limiters
  • 14.4 COMPETITIVE MARKET SHARE ANALYSIS

APPENDIX II: CRYOABLATION GENERATOR MARKET

  • 15.1 INTRODUCTION
  • 15.2 MARKET ANALYSIS AND FORECAST
  • 15.3 DRIVERS AND LIMITERS
    • 15.3.1 Market Drivers
    • 15.3.2 Market Limiters
  • 15.4 COMPETITIVE MARKET SHARE ANALYSIS

APPENDIX III: EXTERNAL DEFIBRILLATOR MARKET

  • 16.1 INTRODUCTION
    • 16.1.1 Automated External Defibrillator
    • 16.1.2 Wearable Cardioverter Defibrillator
  • 16.2 MARKET OVERVIEW
  • 16.3 MARKET ANALYSIS AND FORECAST
    • 16.3.1 Total External Defibrillator Market
    • 16.3.2 Automated External Defibrillator Market
    • 16.3.3 Wearable Cardioverter Defibrillator Market
  • 16.4 DRIVERS AND LIMITERS
    • 16.4.1 Market Drivers
    • 16.4.2 Market Limiters
  • 16.5 COMPETITIVE MARKET SHARE ANALYSIS

ABBREVIATIONS

Back to Top